AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹1,809 Cr | ₹867 Cr | ₹903 Cr | ₹807 Cr | ₹555 Cr |
What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹1,809 Cr |
Mar2023 | ₹867 Cr |
Mar2022 | ₹903 Cr |
Mar2021 | ₹807 Cr |
Mar2020 | ₹555 Cr |
How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,809 Cr | 108.67 | |
Mar2023 | ₹867 Cr | -4.01 | |
Mar2022 | ₹903 Cr | 11.87 | |
Mar2021 | ₹807 Cr | 45.43 | |
Mar2020 | ₹555 Cr | - |
Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹81,001.3 Cr | -0.1% | -6.4% | 63.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,418.0 Cr | -1.2% | -4.7% | 58.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,680.0 Cr | 0.8% | 7.1% | 73.4% | Stock Analytics | |
CIPLA | ₹128,755.0 Cr | 2.7% | -2.8% | 32.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,720.0 Cr | 2.3% | -2.2% | 20.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,120.0 Cr | -0.7% | -5.6% | 69.2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -0.1% |
-6.4% |
63.5% |
SENSEX | 0.6% |
-0.8% |
25.4% |
You may also like the below Video Courses